|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Prospective comparison between double-balloon enteroscopy and spiral enteroscopy显示文摘 | T. Frieling J. Heise W. Sassenrath A. Hülsdonk C. Kreysel | 2010 | Endoscopy2010，，： | 2 |
| 2 | Initial manifestation of eruptive examthematous psoriasis vulgaris caused by captopril medication显示文摘 | Hauschild TT Bauer R Kreysel HW | 1986 | Hautarzt1986，37，5： | 1 |
| 3 | A possible role of lysosomal enzymes in the pathogenesis of varicosis and the reduction in their serum activity by Venostation 显示文摘 | Kreysel H W Nissen H P Enghefer E | 1983 | Vasa1983，12，4： | 1 |
| 4 | Krefelder CONTRA-Studie: Konventionelle diagnostische perorale ?sophago-Gastro-Duodenoskopie (?GD) vs. transnasale ?GD – eine prospektive randomisierte Studie zur unabh?ngigen Evaluation der Sedoanalgesie, des Endoskopdurchmessers und des Zugangswegs显示文摘 | T. Frieling P. Schindler R. Kuhlbusch-Zicklam J. Heise A. Hülsdonk C. Kreysel | 2010 | Z Gastroenterol2010，，08： | 1 |
| 5 | Superoxide dismutase in human semen显示文摘 | H. P. Nissen H. W. Kreysel | 1983 | Klinische Wochenschrift1983，，1： | 1 |
| 6 | Sedation-associated complications in en doscopy-prospective muhicentre survey of 191142 patients显示文摘 | FRILLING T HEISE J KREYSEL C | 2013 | Z Gastroretreol2013，51，6： | 1 |
| 7 | Prospektive und randomisierte Studie zur überprüfung der klinischen Wertigkeit der Kappenkoloskopie (CAC)显示文摘 | T. Frieling F. Neuhaus R. Kuhlbusch-Zicklam J. Heise C. Kreysel A. Hülsdonk M. Blank M. Czypull | 2013 | Z Gastroenterol2013，，12： | 1 |
| 8 | Sedierungsassoziierte Komplikationen w?¤hrend der Endoskopie - eine prospektive multizentrische Erfassung von 191142 Patienten显示文摘 | T. Frieling J. Heise C. Kreysel R. Kuhlen M. Schepke | 2013 | Z Gastroenterol2013，，06： | 1 |
| 9 | Die Kappen-assistierte Koloskopie (CAC) erweitert signifikant die einsehbare Oberfl?che im rechtsseitigen Kolon显示文摘 | T. Frieling F. Neuhaus J. Heise C. Kreysel A. Hülsdonk M. Blank M. Czypull | 2012 | Z Gastroenterol2012，，03： | 1 |
| 10 | Krefelder CONTRA-Studie: Konventionelle diagnostische perorale ?sophago-Gastro-Duodenoskopie (?GD) vs. transnasale ?GD – eine prospektive randomisierte Studie zur unabh?ngigen Evaluation der Sedoanalgesie, des Endoskopdurchmessers und des Zugangswegs显示文摘 | T. Frieling P. Schindler R. Kuhlbusch-Zicklam J. Heise A. Hülsdonk C. Kreysel | 2010 | Z Gastroenterol2010，，08： | 1 |
| 11 | A possible role of lysosomal enzymes in the pathogenesis of varicosis and the reduction in their serum activity by Venostation显示文摘 | Kreysel HW | 1983 | Vasa1983，12，4： | 1 |
| 12 | Sedation-associated complications in endoscopy-prospective muhicentre survey of 191142 patients 显示文摘 | Frieling T Heise J Kreysel C | 2013 | Z Gastroenterol2013，51，6： | 1 |
| 13 | Polyunsaturated fatty acids in relation to sperm motility 显示文摘 | Nissen H P Kreysel I4 W | 1983 | Andrologia1983，15，3： | 1 |
| 14 | Superoxide dismutase in human semen显示文摘 | H. P. Nissen H. W. Kreysel | 1983 | Klinische Wochenschrift1983，，1： | 1 |
| 15 | High-dose interferon-α2b induction therapy in combination with ribavirin for treatment of chronic hepatitis C in patients with non-response or relapse after interferon-a monotherapy显示文摘AIM: To evaluate the daily high-dose induction therapy with interferon-α2b (IFN-α2b) in combination with ribavirin for the treatment of patients who failed with interferon monotherapy and had a relapse, based on the assumption that the viral burden would decline faster, thus increasing the likelihood of higher response rates in this diffficult-to-treat patient group.METHODS: Seventy patients were enrolled in this study.Treatment was started with 10 MU IFN-α2b daily for 3 wk,followed by IFN-α2b 5 MU/TIW in combination with ribavirin (1 000-1 200 mg/d) for 21 wk. In case of a negative HCV RNA PCR, treatment was continued until wk 48 (IFN-α2b 3 MU/TIW+1 000-1 200 mg ribavirin/daily).RESULTS: The dose of IFN-α2b or ribavirin was reduced in 16% of patients because of hematologic side effects,and treatment was discontinued in 7% of patients. An early viral response (EVR) was achieved in 60% of patients. Fifty percent of all patients achieved an end-of-treatment response (EOT) and 40% obtained a sustained viral response (SVR). Patients with no response had a significantly lower response rate than those with a former relapse (SVR 30% vs 53%; P = 0.049). Furthermore,lower response rates were observed in patients infected with genotype 1a/b than in patients with non-1-genotype (SVR 28% vs74%; P= 0.001). As a significant predictive factor for a sustained response, a rapid initial decline of HCV RNA could be identified. No patient achieving a negative HCV-RNA PCR at wk 18 or later eventually eliminated the virus.CONCLUSION: Daily high-dose induction therapy with interferon-α2b is well tolerated and effective for the treatment of non-responders and relapsers, when interferon monotherapy fails. A fast decline of viral load during the first 12 wk is strongly associated with a sustained viral response. | Holger G. Hass Christian Kreysel Johannes Fischinger Josef Menzel Stephan Kaiser | 2005 | World Journal of Gastroenterology2005，11，34： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员